Overview

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

Status:
Not yet recruiting

Trial end date:
2026-01-31

Target enrollment:

Participant gender:

Summary

This is a prospective, single-arm, single-center, phaseⅡtrial to evaluate the efficacy and safety of Paclitaxel Polymeric Micelles for Injection, platinum (cisplatin/carboplatin) in combination with sindilizumab injection as first-line chemotherapy in advanced or metastatic non-squamous NSCLC patients without EGFR mutation or ALK rearrangement.

Phase:

Phase 2

Details

Lead Sponsor:

Jiangsu Cancer Institute & Hospital

Treatments:

Paclitaxel